AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2014

Jan 9, 2014

30291_dirs_2014-01-09_47c40069-2983-4ab9-8951-c82beeaf8c2d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2014-01-08

Reporting Person: YOUNG WILLIAM (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-08	Common Stock	S	15000	$285.106	Disposed	18509	Direct

Footnotes

F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities and Exchange Act of 1934.

F2: This represents the weighted average price for shares sold at a range between $285 (low) and $285.21 (high).

F3: Full information regarding the number of shares sold at each separate price will be provided upon requst by the SEC staff, the issuer, or a security holder of the issuer.